KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,119,000 | +728.9% | 1,042,000 | +462.0% | 0.28% | +751.5% |
Q2 2022 | $1,824,000 | -43.3% | 185,400 | -55.9% | 0.03% | -38.9% |
Q1 2020 | $3,218,000 | +12.6% | 420,641 | +162.0% | 0.05% | +31.7% |
Q4 2019 | $2,859,000 | +536.7% | 160,541 | +314.5% | 0.04% | +355.6% |
Q3 2019 | $449,000 | -82.7% | 38,733 | -57.2% | 0.01% | -77.5% |
Q1 2019 | $2,590,000 | – | 90,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,551,719 | $22,515,000 | 5.42% |
Prosight Management, LP | 530,062 | $7,691,000 | 4.12% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $26,118,000 | 3.20% |
Vivo Capital, LLC | 1,533,559 | $22,252,000 | 2.46% |
Frazier Life Sciences Management, L.P. | 1,572,192 | $22,813,000 | 1.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 316,133 | $4,587,000 | 1.47% |
Deep Track Capital, LP | 1,824,000 | $26,466,000 | 1.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,707,100 | $24,770,000 | 1.03% |
DAFNA Capital Management LLC | 255,313 | $3,705,000 | 1.00% |
COMMODORE CAPITAL LP | 312,553 | $4,535,000 | 0.73% |